Wearable Injectors Market – By Global Industry Analysis, Size, Share, Trends, Forecast 2016 – 2024

Wearable Injectors Market SizeThe global wearable injectors market is likely to grow from $2,162.1 million in 2015 to $13.0 billion by 2024. With the explosive growth of bolus injectors and increasing interest of pharmaceutical companies in collaborating with device manufacturers for drug device combination, the market for wearable injectors is expected to show dramatic rise. The launch of bolus injector expands the usage of wearable injectors from diabetes to other disease segments, as the wearable injectors currently available in market are majorly insulin pumps. The growing need for continuous and subcutaneous drug delivery has developed the demand for wearable injectors among the patients.

Explore Report Sample at: http://bit.ly/2fdS4t1

As per the findings of the research, cancer is expected to be the largest application area of wearable injectors. According to the analyst, cancer and autoimmune disease are expected to be the major application areas for wearable injectors in the near future. The other key applications of wearable injectors include infectious disease, cardiovascular disease and blood disorders. Also, homecare is expected to be the largest end user of wearable injectors.

Growing need for advanced drug delivery is one of the major factors driving the growth of the global wearable injectors market. Increasing demand for homecare and advanced drug delivery requiring minimal expertise and lesser hospitalization of patients is expected to drive the demand for wearable injectors, globally. Also, many biopharmaceutical companies have been looking for a better mode of drug delivery for their portfolio of biologic drugs, for which wearable injectors are an appropriate solution.

Access Report Overview: http://bit.ly/2yYp3sD

The research states that the global wearable injectors market had a consolidated structure in 2015, where the top three competitors accounted for the major share in the global wearable injectors market. Some of the key players operating in the global market are Becton, Dickinson and Company, Medtronic plc, Johnson & Johnson, F. Hoffmann-La Roche Ltd., Insulet Corporation, Unilife Corporation, CeQur SA, Enable Injections, ScPharmaceuticals, Inc., SteadyMed Ltd., Ypsomed Group, West Pharmaceutical Services, Inc. and Canè S.p.A.


Healthcare EDI Market Analysis, Size, Growth and Demand, 2023

Healthcare electronic data interchange MarketHealthcare electronic data interchange (EDI) facilitates the exchange of healthcare data which is processed using computer software in a standardized format. Healthcare industry processes a large number of documents such as medical records of patients, healthcare claims, and reimbursement records. Healthcare EDI helps in the exchange of this information among healthcare institutions, healthcare professionals, and patients.

Explore Report at: https://www.psmarketresearch.com/market-analysis/healthcare-edi-market

The use of healthcare EDI increases accuracy, improves productivity, helps in faster identification of errors, consumes less time, secures exchange of information and leads to ease of work for the healthcare providers, healthcare payers, and pharmacies. Healthcare EDI finds application in insurance and reimbursement data management, clinical trials and regulatory data management, and medical and dental patient database management. They key players such as Dell Technologies Inc. are prompting the growth of the global healthcare EDI market. In February 2017, Dell Technologies Inc. quickened the digital transformation in healthcare EDI market with the introduction of cloud integration solution for healthcare EDI.

Global healthcare EDI market is expected to grow significantly during the forecast period. Some of the major factors driving growth of the market include expanding base of patient due to the increasing prevalence of chronic diseases, rising need to curtail healthcare costs, and government support for healthcare EDI.

According to the World Health Organization (WHO), chronic disease is the leading cause of mortality globally, comprising 60% of all deaths. Also, approximately 17.7 million people died from cardiovascular diseases in 2015, representing 31% of all global deaths. Of these deaths, an approximate of 7.4 million deaths were due to coronary heart disease and 6.7 million were due to stroke. WHO also reported that globally 8.8 million people died from cancer which is 1 in 6 of all global deaths in 2015. With the rise in these chronic diseases, the volume of patient is also increasing. Moreover, these large number of deaths also prompts the end users to avail healthcare EDI products for different reimbursements claims.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/healthcare-edi-market/report-sample

Some of the key players in the global healthcare EDI market are GE Healthcare, Cognizant Technology Corporation, Cerner Corporation, Axway Software SA, Dell Technologies Inc., Synnex Corporation, McKesson Corporation, Allscripts Healthcare Solutions Inc., SSI Group, LLC, Comarch SA, Optum Inc., and Quality Systems Inc.

Surgical Navigation System Market – New Business Opportunities & Investment Research Report, 2023

Surgical Navigation System MarketSurgical navigation system, also known as computer assisted surgery, is a revolutionized surgical procedure. It utilizes medical devices with navigation system on it to track the patient’s body at the diseased position, and provides a 3D image that assists surgeons to perform high-precision minimal invasive surgeries. This innovative and technologically advanced procedure has led the growth of global surgical navigation system market. As per the World Health Organization (WHO), the global volume of surgeries in  2012 ranged around 266.2–359.5 million and is expected to increase over the years. With the rise in surgical rate and advancement in technology, the demand of surgical navigation system is growing and is expected to witness a gradual increase during the forecast period (2017-2023).

Explore Report at: https://www.psmarketresearch.com/market-analysis/surgical-navigation-system-market

The global surgical navigation system market is segmented on the basis of application, technology and end user. On the basis of application, the market is segmented into neuro navigation system, ENT navigation system, ortho navigation system, spinal navigation system, dental navigation system and cardiac navigation system. Among the varied application segments, ENT navigation system has been observed to be the largest contributor and is expected to remain so during the forecast period, due to the increasing prevalence of ENT related disorders and associated surgical procedures. Based on technology, the global surgical navigation system market is segmented into optical navigation system, electromagnetic navigation system, hybrid navigation system, fluoroscopy based navigation system, CT based navigation system and other navigation systems. Optical navigation system is anticipated to be the fastest growing technology in the global market due to its preference over electromagnetic navigation system. Optical navigation system is precise, and its reduced exposure to radiation is expected to drive it to have highest growth during the forecast period.

Explore Report sample at: https://www.psmarketresearch.com/market-analysis/surgical-navigation-system-market/report-sample

The global surgical navigation system market is a technology driven market and with the advancements in the field of navigation system and medical devices, the global market is expected to grow significantly during the forecast period. The other major driving force behind this growth are the increase in prevalence of chronic diseases such as neurological disorders, orthopedic disorders; the initiatives by government organization to provide support to research and development (R&D) and regulatory approvals. Further, the rise in ENT related disorders such as, chronic sinusitis that demand surgical interventions will drive the growth of the market.

The other key players in the global surgical navigation system market are Medtronic PLC, Stryker Corporation, Brainlab AG, B. Braun Melsungen AG, OrthAlign, Inc., Scopis GmbH, Fiagon GmbH, Zimmer Biomet Holdings, Inc., and Siemens AG.

Advanced Visualization Industry Outlook, Growth Prospects and Key Opportunities

Advanced Visualization MarketThe global advanced visualization market is likely to grow from $1.8 billion in 2016 to $3.8 billion by 2023. Technological advancements, increasing demand for efficient and early diagnosis of diseases, and increasing prevalence of chronic diseases have been driving the growth of the global advanced visualization market. The market is further expected to gain revenue due to increasing geriatric population and incorporation of advanced visualization solutions in mobile devices. Integration of picture archiving and communication system (PACS) and advanced visualization solutions along with the rising demand from developing nations would create ample opportunities for the global advanced visualization vendors.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/advanced-visualization-market/report-sample

North America has been the largest market for advanced visualization, with the U.S. being the larger contributor to the regional market as compared to Canada. The key factor driving the North American advanced visualization market are technological advancements, increasing healthcare expenditure, growing geriatric population, improved healthcare infrastructure and growing prevalence of chronic diseases. According to the World Health Organization, approximately 324,000 new cases of lung cancer were diagnosed in North America in 2012, and the number is estimated to reach approximately 541,000 by 2030. The emerging economies in Asia-Pacific, especially China and India, are expected to grow tremendously in future, which is expected to bring the Asia-Pacific market approximately equal to the European market by 2023.

Key companies in the advanced visualization market are collaborating to offer better advanced visualization solutions. In November 2016, TeraRecon, released an advanced integration between iNtuition with Agfa HealthCare’s Enterprise Imaging 8.1. The combined solution provides single user interface for accessing 2D and advanced 3D applications, bi-directional communication between Agfa and TeraRecon viewers, and multi-series data loading for 3D analysis.

Browse More Information on Advanced Visualization Market: https://www.psmarketresearch.com/market-analysis/advanced-visualization-market

Some of the other key players in the market include General Electric Company, Canon, Inc., Siemens AG, Koninklijke Philips N.V, Fujifilm Holdings Corporation, Carestream Health, Agfa-Gevaert N.V., and Ziosoft.

Biosimulation Technology Market – Global Industry Insights, Analysis and Growth, 2023

Biosimulation Technology Market

The global biosimulation market is growing significantly due to technological advancements and increasing research and development investment in the pharmaceutical and biotechnology industries. Low success rate of drug approval and emerging software applications of biosimulation technology are creating ample opportunities for the global biosimulation technology market to grow at a significant rate in the forecasted period.The advanced research and development facilities and new product developments by the companies are propelling the demand for cost effective biosimulation software.

Explore Report at: https://www.psmarketresearch.com/market-analysis/biosimulation-technology-market

In biosimulation industry, there is a trend of collaboration and partnership of universities and research institutes with suppliers. Drug discovery and development process is stringent, time consuming, and expensive process. In addition, the success rate of drug approval is very low. According to Tufts Centre for the Study of Drug Development, an academic, non-profit research group at Tufts University, in the U.S., out of 1,000 compounds tested only one makes it to human clinical trials, and out of five such compounds only one gets approved. Biosimulation technology overcomes these limitations by simulating biological systems through software models and increasing predictability in early stages of drug development; hence, saving time and money in drug development process.

Biosimulation technology market can be categorized on the basis of applications, end-users, and product types. Based on applications, the biosimulation technology market can be categorized as drug development, drug discovery, and others. Drug development segment includes preclinical testing and clinical trials; whereas, drug discovery segment includes target identification and validation, and lead identification and optimization. Drug development segment leads the biosimulation technology market. Based on end-users, biosimulation technology market can be categorized as pharmaceutical and biotechnology companies, academic institutes and research laboratories, contract research organizations, and others. Pharmaceutical and biotechnology companies lead the biosimulation technology market.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/biosimulation-technology-market/report-sample

Some of the major players operating in the global biosimulation technology market Dassault Systemes SA, Simulation Plus Inc., Certara USA, Inc., Advanced Chemistry Development, Inc., In Silico Biosciences, Inc., Chemical Computing Group, Inc., Physiomics PLC., Rhenovia Pharma Ltd., Genedata AG, Entelos Holding Corporation, Leadscope, Inc., and Schrodinger Inc. among others.

Influenza Vaccine Market – Global Industry Size, Share and Growth, 2023

Influenza Vaccine MarketThe global influenza vaccine market is growing significantly due increasing awareness about the pandemic influenza viruses and increasing government involvement for vaccination against influenza viruses. Massive unexplored influenza vaccine markets in the emerging economies are creating ample opportunities for the global influenza vaccine market to grow at a significant rate in the forecasted period. The advanced research and development facilities and new vaccine developments by the companies are propelling the demand for safe and efficacious influenza vaccine. Influenza (flu) is a respiratory disease caused by mainly two types of influenza viruses namely, influenza A and B viruses. Influenza A viruses are of two types based on the proteins on the surface of virus: hem agglutinin (H) and neuraminidase (N).

Explore Report at: https://www.psmarketresearch.com/market-analysis/influenza-vaccine-market

In global influenza vaccine industry, there is a trend of development of intranasal vaccine due to the ease of self-administration. According to Centers for Disease Control and Prevention (CDC),in 2009, approximately 151,700 to 575,400 people died due to H1N1 influenza pandemic or swine flu across the globe. In addition, the organization also reported that most deaths due to 2009 flu pandemic occurred in Africa and Southeast Asia region. Several vaccines have been developed to prevent pandemic and seasonal influenza viruses using recombinant DNA technology and extensive researches are going on to develop efficient influenza vaccines using cell culture technology. Various governmental and non-governmental organizations have been actively involved in promoting and monitoring vaccination programs aimed at immunising people against seasonal influenza viruses. This in turn fuels the growth of global influenza vaccine market.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/influenza-vaccine-market/report-sample

Some of the major players operating in the global influenza vaccine market are GlaxoSmithKline,Sanofi Pasteur, Inc., ID Biomedical Corporation, CSL Limited, Novartis, Protein Sciences Corporaton, MedImmune, LLC, Sinovac Biotech, Serum Institute of India, and Hualun Biologicalsamong others.